Viewing nowFosidi Tablet 10 mg (Dapagliflozin Anhydrous Mixed Preparation)
Dapagliflozin Anhydrous Lactose Mixture 15.27mg
Tablet · Prescription medication
International Pharmaceutical Co., Ltd.

MFDS item code 202005319 · Approved 2020.07.23 · Insurance code 643705380
Improvement of glycemic control in type 2 diabetes mellitus
This medication is used in conjunction with dietary changes and exercise to help control blood sugar levels in patients with Type 2 diabetes. It can be administered alone or in combination with other medications. It is particularly important to refer to expert guidance regarding the effect on the occurrence of cardiovascular events in patients with cardiovascular disease or risk factors whose blood sugar control is inadequate. This medication helps improve blood sugar control and maintain health.
Type 2 diabetes mellitus Monotherapy and add-on combination therapy The recommended dose of this medicine is 10mg once daily for monotherapy and add-on combination therapy with other glucose-lowering agents, including insulin. When this medicine is used in combination with insulin or an insulin secretagogue such as a sulfonylurea, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. Initial combination therapy For patients who have not previously received drug treatment for diabetes, when used in combination with metformin, the recommended starting dose of this medicine is 5mg once daily or 10mg once daily. Special populations Renal impairment - eGFR less than 45 mL/min/1.73m2: Use of this medicine to improve glycemic control is not recommended. - Patients on dialysis: Do not administer this medicine. Hepatic impairment No dose adjustment is required in patients with mild or moderate hepatic impairment. For patients with severe hepatic impairment, a starting dose of 5 mg is recommended. If well tolerated, this dose may be increased to 10mg. Elderly patients (≥ 65 years) Dose adjustment based on age is not recommended. Method of administration This medicine may be administered orally once daily at any time of day, with or without food. Swallow the tablet whole.
The efficacy and safety of dapagliflozin in children under 18 years of age have not been established. No relevant data are available.
This medication should not be administered to certain patients. For example, it must not be used in patients who are allergic to its components, individuals with Type 1 diabetes, those with diabetic ketoacidosis, genetically lactose intolerant patients, and patients undergoing dialysis. Caution should be exercised when administering to patients with low fluid volume or poor kidney function. This medication may lower blood pressure or affect kidney function, so blood pressure and kidney function must be carefully monitored before and after administration. The effect of this medication on blood sugar control varies based on kidney function; therefore, it is not recommended for patients with moderate or severely decreased kidney function for blood sugar control purposes. Moreover, this medication contains the colorants Yellow No. 4 and Yellow No. 5, necessitating caution for patients who are allergic or sensitive to these components. The most common side effect when taking this medication is genital infections, which may occur more frequently in female patients. Other side effects reported include urinary tract infections, hypoglycemia, decreased fluid volume, dizziness, constipation, dry mouth, and lower back pain. Especially, there is a rare occurrence of a serious metabolic disorder called diabetic ketoacidosis, so if symptoms like dehydration, vomiting, abdominal pain, or difficulty breathing occur, immediate medical consultation is necessary. The risk of hypoglycemia may increase when this medication is used in conjunction with other antidiabetic agents, so dosage adjustments may be necessary when used with insulin or sulfonylureas. It is advisable for pregnant or breastfeeding women to avoid using this medication, and if pregnancy is confirmed, immediate discontinuation of administration should take place. Elderly patients or those with decreased kidney function are at higher risk for decreased fluid volume and hypotension, so caution is needed. During use of this medication, glucose may be detected in urine tests, so this should be noted. There is no specific antidote for overdose; symptom-related treatment should be given according to a doctor's instructions. Finally, this medication does not significantly affect the ability to drive or operate machinery, but caution is required due to the risk of hypoglycemia.
Vulvovaginitis, balanitis and related genital infections, urinary tract infections, fungal infections, perineal necrosis, hypoglycemia, decreased fluid volume, thirst, diabetic ketoacidosis, dizziness, constipation, dry mouth, back pain, dysuria, polyuria, nocturia, interstitial nephritis, vulvar pruritus, genital pruritus, elevated hematocrit, decreased renal creatinine clearance at the beginning of treatment, dyslipidemia, increased serum creatinine at the beginning of treatment, elevated blood urea, weight loss, rash, angioedema, urosepsis, pyelonephritis, acute kidney injury, renal dysfunction, asthenia, pain, keratitis, chronic obstructive pulmonary disease, hemoptysis, cerebral hemorrhage, peripheral artery occlusion, angina, myocardial infarction, bile duct stone, cholangitis, alcoholic cirrhosis, depression, suicide attempt, gastric adenocarcinoma, anaphylactic reaction, acute pyelonephritis, chest pain, chronic gastritis, diverticulosis, gastric intestinal air retention, frequent bowel movements, gastroenteritis, colonic polyps, intestinal perforation, epigastric discomfort, functional dyspepsia, erosive gastritis, gum disorders, gum pain, hemorrhoids, hiatal hernia, irritable bowel syndrome, melena, chronic pancreatitis, urgency to urinate, diabetic nephropathy, overactive bladder, microalbuminuria, stress urinary incontinence, hesitancy in urination, urinary stones, abnormal urination, increased blood lactate, lymphocytopenia, weight gain, vitamin D deficiency, increased appetite, taste disturbance, drowsiness, tension headache, carpal tunnel syndrome, diabetic neuropathy, unconsciousness, nerve compression, neuralgia, peripheral neuropathy, sleep disorders, syncope, tremors, bronchitis, herpes zoster, sinusitis, tonsillitis, herpes simplex, stye, joint abscess, laryngitis, otitis media, pelvic inflammatory disease, pericoronitis, pneumonia, pulmonary tuberculosis, rhinitis, onychomycosis, herpes simplex, edema, fever, foreign body sensation, facial edema, facial pain, warmth, influenza-like symptoms, fatigue, chest discomfort, peripheral edema, generalized edema, hunger, vaginal discharge, menstrual irregularity, pruritus, urticaria, cold sweat, arthralgia, musculoskeletal pain, limb pain, muscle weakness, myalgia, osteoarthritis, ligament sprain, diabetic retinopathy, cough, dyspnea, orthostatic hypotension, palpitations, insomnia, fatty liver, gallbladder polyp, tinnitus
Not everyone experiences these, and they can vary from person to person.
This medication should be kept in a tightly closed container to prevent air or moisture exposure and stored at room temperature between 1 and 30 degrees Celsius. This helps maintain the medication's efficacy and ensures safe use.
Yellow, biconvex, diamond-shaped film-coated tablet
28 tablets/box [14 tablets/PTP × 2]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowDapagliflozin Anhydrous Lactose Mixture 15.27mg
Tablet · Prescription medication
International Pharmaceutical Co., Ltd.
Dapagliflozin Anhydrous Lactose Mixture 7.635mg
Tablet · Prescription medication
International Pharmaceuticals Co., Ltd.
Dapagliflozin Anhydrous Lactose Mixture 7.635mg
Tablet · Prescription medication
Shinil Pharmaceutical Co., Ltd.

Dapagliflozin Anhydrous Lactose Mixture 15.27mg
Tablet · Prescription medication
Sinil Pharmaceutical Co., Ltd.
Dapagliflozin Anhydrous Lactose Mixture 7.635mg
Tablet · Prescription medication
Dongwha Pharmaceutical Co., Ltd.

Dapagliflozin Anhydrous Lactose Mixture 15.27mg
Tablet · Prescription medication
Donghwa Pharmaceutical Co., Ltd.
Dapagliflozin Anhydrous Lactose Mixture 7.635mg
Tablet · Prescription medication
Albozen Korea Co., Ltd.

Dapagliflozin Anhydrous Lactose Mixture 15.27mg
Tablet · Prescription medication
AlboGen Korea Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.